Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Mori (Sagamihara, Japan), S. Kouyama (Sagamihara, Japan), M. Yamaguchi (Sagamihara, Japan), C. Kumitani (Sagamihara, Japan), A. Ohtomo-Abe (Sagamihara, Japan), N. Fujita (Sagamihara, Japan), M. Iwata (Sagamihara, Japan), K. Nagayama (Sagamihara, Japan), K. Ryu (Sagamihara, Japan), Y. Nakamura (Sagamihara, Japan), Y. Tomita (Sagamihara, Japan), Y. Hamada (Sagamihara, Japan), H. Hayashi (Sagamihara, Japan), K. Watai (Sagamihara, Japan), Y. Kamide (Sagamihara, Japan), K. Sekiya (Sagamihara, Japan), Y. Fukutomi (Sagamihara, Japan), M. Taniguchi (Sagamihara, Japan), T. Ohtomo (Hachioji, Japan), O. Kaminuma (Chuo, Japan). Late Breaking Abstract - Pharmacological characterization of T cell-induced broncho-constriction in vitro and in vivo. 1646

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Immunomodulatory protein ATYR1923 disrupts an in vitro model of sarcoid granuloma formation Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys Year: 2021 Late Breaking Abstract - IgE-FceR1 cross-linking impairs the capacity of plasmacytoid dendritic cells to induce in vitro functional regulatory T cells which can be restored by Omalizumab Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019 Late Breaking Abstract -  Effect of Hypercapnia in human primary culture of alveolar cells in vitro Source: International Congress 2018 – Preclinical and clinical studies of critical illness Year: 2018 Late Breaking Abstract - Elevated NETosis and migration but impaired anti-microbial responses by COVID-19 neutrophils Source: Virtual Congress 2021 – Acute COVID - 19 Year: 2021 Late Breaking Abstract - Hypoxia dampens the allergen-dependent adaptive immune response and ameliorates allergic asthma in vivo Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials Year: 2021 Late Breaking Abstract - SARS-CoV-2 induces hyperinflammation in human macrophages via TLR4 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021 Late Breaking Abstract - Anti-inflammatory and anti-fibrotic effect of novel, pan-PDE inhibitors in human bronchial epithelial cells Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 Late Breaking Abstract - Role of interleukin-10 in normal and aberrant late lung development Source: International Congress 2017 – Postnatal lung growth and development Year: 2017 Modeling in vitro, ex vivo or in vivo? Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development Year: 2013 Late Breaking Abstract - Human lung microbiota-driven differential innate immune landscape Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Late Breaking Abstract - Title: Air-born allergens modulate the immunological lung microenvironment. Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017 Late Breaking Abstract - Identification and functional testing of a novel receptor for SP-A on eosinophils Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Late Breaking Abstract: Activation of the WNT/β-catenin pathway attenuates experimental emphysema Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Late Breaking Abstract - CRAC channel inhibition by RP3128 triggers potent anti-inflammatory effects in COPD or asthmatic patient-derived primary cells Source: International Congress 2018 – New pharmacological strategies in airway diseases Year: 2018 Synergistic suppression of T cell-induced eosinophilia by CTLA4-Ig and glucocorticoid in murine asthma model Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Late Breaking Abstract: The role of galectin-3 on macrophages in CNT-induced mouse lung inflammation Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010 Late Breaking Abstract - Copper-heparin counteracts elastase-induced emphysema formation Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Late Breaking Abstract - GATA-3 in lung CD4+T cells drives Interleukin-10 deficiency-induced lung inflammation in asthma Source: Virtual Congress 2020 – New insights into asthma immunology: in mouse and men Year: 2020 Late Breaking Abstract - Novel mesenchymal pathways that initiate emphysema Source: International Congress 2018 – Intercellular communication in tissue remodelling Year: 2018 Late Breaking Abstract - Aerobic exercise reduces asthma phenotype by inhibiting purinergic signaling and lymphatic organs hyperactivation Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017